Judith E Mueller

Summary

Country: France

Publications

  1. pmc Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    Emerg Infect Dis 13:847-54. 2007
  2. pmc Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso
    Isabelle Delrieu
    Agence de Medecine Preventive, Paris, France
    PLoS ONE 6:e19513. 2011
  3. doi Association of respiratory tract infection symptoms and air humidity with meningococcal carriage in Burkina Faso
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    Trop Med Int Health 13:1543-52. 2008
  4. ncbi Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    J Infect Dis 193:812-20. 2006
  5. doi A hypothetical explanatory model for meningococcal meningitis in the African meningitis belt
    Judith E Mueller
    Agence de Medecine Preventive, Institut Pasteur, 25 28 Rue du Dr Roux, 75724 Paris Cedex 15, France
    Int J Infect Dis 14:e553-9. 2010
  6. ncbi Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines
    Judith E Mueller
    Agence de Medecine Preventive, 25 du Dr Roux, 75724 Paris Cedex 15, France
    Expert Rev Vaccines 5:319-36. 2006
  7. pmc Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba Province, Argentina
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    Appl Environ Microbiol 75:1395-401. 2009
  8. pmc Pneumococci in the African meningitis belt: meningitis incidence and carriage prevalence in children and adults
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    PLoS ONE 7:e52464. 2012
  9. doi Pneumococcal serotype distribution among meningitis cases from Togo and Burkina Faso during 2007-2009
    Bradford D Gessner
    Agence de Medecine Preventive, Paris, France
    Vaccine 30:G41-5. 2012
  10. pmc Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    J Infect Dis 204:1787-95. 2011

Collaborators

Detail Information

Publications23

  1. pmc Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    Emerg Infect Dis 13:847-54. 2007
    ..These findings show the need for large samples and a longitudinal design for N. meningitidis serogroup A carriage studies...
  2. pmc Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso
    Isabelle Delrieu
    Agence de Medecine Preventive, Paris, France
    PLoS ONE 6:e19513. 2011
    ..Although limited to a few districts, we have documented NmX meningitis epidemics occurring with a seasonal incidence previously only reported in the meningitis belt for NmW135 and NmA, which argues for development of an NmX vaccine...
  3. doi Association of respiratory tract infection symptoms and air humidity with meningococcal carriage in Burkina Faso
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    Trop Med Int Health 13:1543-52. 2008
    ..To evaluate risk factors for meningococcal carriage and carriage acquisition in the African meningitis belt, comparing epidemic serogroup A (NmA) to non-epidemic serogroups...
  4. ncbi Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    J Infect Dis 193:812-20. 2006
    ..meningitidis serogroup W-135 and serogroup A disease are hyperendemic and most of the population received polysaccharide A/C vaccine during 2002...
  5. doi A hypothetical explanatory model for meningococcal meningitis in the African meningitis belt
    Judith E Mueller
    Agence de Medecine Preventive, Institut Pasteur, 25 28 Rue du Dr Roux, 75724 Paris Cedex 15, France
    Int J Infect Dis 14:e553-9. 2010
    ..Epidemic waves occur if new meningococcal strains which escape pre-existing immunity, enter the population. Future research should include the impact of viral co-infection on bacterial colonization and invasion...
  6. ncbi Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines
    Judith E Mueller
    Agence de Medecine Preventive, 25 du Dr Roux, 75724 Paris Cedex 15, France
    Expert Rev Vaccines 5:319-36. 2006
    ..This review summarizes the existing data on N. meningitidis W135 epidemiology, immunology and vaccines as they relate to meningitis in sub-Saharan Africa...
  7. pmc Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba Province, Argentina
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    Appl Environ Microbiol 75:1395-401. 2009
    ....
  8. pmc Pneumococci in the African meningitis belt: meningitis incidence and carriage prevalence in children and adults
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    PLoS ONE 7:e52464. 2012
    ..The development of optimal vaccination strategies for pneumococcal conjugate vaccines requires serotype-specific data on disease incidence and carriage prevalence. This information is lacking for the African meningitis belt...
  9. doi Pneumococcal serotype distribution among meningitis cases from Togo and Burkina Faso during 2007-2009
    Bradford D Gessner
    Agence de Medecine Preventive, Paris, France
    Vaccine 30:G41-5. 2012
    ..Pneumococcal meningitis was highly seasonal regardless of serotype. Data from this study emphasize the potential usefulness of PCVs among older children and adults...
  10. pmc Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    J Infect Dis 204:1787-95. 2011
    ..To better understand localized meningococcal meningitis epidemics, we evaluated a serogroup A (NmA) epidemic in Burkina Faso by surveillance, carriage, and seroprevalence studies...
  11. pmc Serotyping pneumococcal meningitis cases in the African meningitis belt by use of multiplex PCR with cerebrospinal fluid
    Berthe Marie Njanpop Lafourcade
    Agence de Medecine Preventive, at the Institut Pasteur, 25 28 Rue du Dr Roux, 75724 Paris Cedex 15, France
    J Clin Microbiol 48:612-4. 2010
    ..In regional meningitis surveillance, CSF-based PCR increased the serotype information yield from 40% of cases (isolate testing) to 90%...
  12. doi Conjugate vaccine introduction in the African meningitis belt: meeting surveillance objectives
    Judith E Mueller
    EHESP French School of Public Health, Sorbonne Paris Cité, Rennes, France and Emerging Disease Epidemiology Unit, Institut Pasteur, Paris, France
    Trop Med Int Health 18:58-64. 2013
    ..Molecular diagnostics will facilitate surveillance in remote areas, but the available techniques should be evaluated for diagnostic performance in the field and long-term sustainability...
  13. pmc Meningitis dipstick rapid test: evaluating diagnostic performance during an urban Neisseria meningitidis serogroup A outbreak, Burkina Faso, 2007
    Angela M C Rose
    Epicentre, Paris, France
    PLoS ONE 5:e11086. 2010
    ..Although the former is the current standard for bacterial meningitis surveillance in the meningitis belt, nested PCR performed in a certified laboratory should be used as an absolute reference when evaluating new diagnostic tests...
  14. pmc African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults
    Bradford D Gessner
    Agence de Medecine Preventive, 25 28 rue du Dr, Roux, Paris 75728, France
    BMC Infect Dis 10:22. 2010
    ..We aimed to collect all available population based data on pneumococcal meningitis throughout life in the African meningitis belt and then to model overall meningitis risk to help inform vaccine policy...
  15. pmc Definition and characterization of localised meningitis epidemics in Burkina Faso: a longitudinal retrospective study
    Haoua Tall
    Agence de Medecine Preventive, Paris, France
    BMC Infect Dis 12:2. 2012
    ..To facilitate research and surveillance, we aimed to develop a definition for localised epidemics to be used in real-time surveillance based on weekly case reports at the health centre level...
  16. ncbi The epidemiology of Neisseria meningitidis meningitis in Togo during 2003-2005
    Kokou Louis Sewonou Adjogble
    Ministère de la Sante Publique du Togo, Lome, Togo
    Vaccine 25:A47-52. 2007
    ..NmW135 meningitis showed pronounced temporal and geographic clustering and occurred almost exclusively among those younger than 15 years old. By the 2004-2005 epidemic season, NmW135 had largely disappeared from Togo for unknown reasons...
  17. ncbi The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005
    Yves Traore
    Universite de Ouagadougou
    Clin Infect Dis 43:817-22. 2006
    ..During the period 2001-2002, Burkina Faso reported its first meningitis epidemic due to Neisseria meningitidis (Nm) serogroup W135, prompting concerns that this serogroup would persist as a cause of epidemic disease...
  18. ncbi Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina Faso
    Helen Findlow
    Vaccine Evaluation Unit, Health Protection Agency North West, Manchester Royal Infirmary, Manchester, M13 9WZ, UK
    J Infect Dis 195:1071-7. 2007
    ..The presence of cnl meningococci that can escape serum killing and cause invasive disease is of concern for future vaccination strategies and should promote rigorous surveillance of cnl meningococcal disease...
  19. ncbi Meningococcal carriage and immunity in western Burkina Faso, 2003
    Seydou Yaro
    Centre Muraz, Bobo Dioulasso, Burkina Faso
    Vaccine 25:A42-6. 2007
    ..A vaccine that is effective against W135 will be beneficial for sub-Saharan Africa...
  20. ncbi The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence
    Paul Daza
    Mzuzu Central Hospital, Mzuzu, Malawi
    Vaccine 24:6232-9. 2006
    ..The most urgent future need is for a sustainable routine infant immunization program, including a less expensive vaccine that preferably is delivered in a multivalent form...
  21. ncbi Prevalence and determinants of hormone replacement therapy in German women 1984-1995
    Judith E Mueller
    Institute of Epidemiology, GSF National Research Centre for Environment and Health, Postfach 1129, D 85758, Neuherberg, Germany
    Maturitas 43:95-104. 2002
    ..To describe trends in prevalence and determinants of hormone replacement therapy (HRT) in German women...
  22. ncbi Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda
    Narcisse Muganga
    Centre Hospitalier Universitaire de Kigali, Rwanda
    Vaccine 25:7001-5. 2007
    ..In an African setting with few resources and in which few confirmed Hib meningitis cases were identified, Hib vaccine impact nevertheless could be demonstrated against the outcome of purulent meningitis and was found to be high...
  23. ncbi Bone metabolism during the perimenopausal transition: a prospective study
    Vanadin Seifert-Klauss
    Frauenklinik der Technischen Universitat Munchen, Klinikum rechts der Isar, Ismaninger Strasse 22, D 81675 Munich, Germany
    Maturitas 41:23-33. 2002
    ..Changes in biochemical markers of bone formation and resorption were followed over the course of 1 year in premenopausal, perimenopausal and early postmenopausal women...